Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

45.60

+1.27 (2.86%)

At close: Jun 23, 2026, 4:00 PM EDT

45.59

-0.01 (-0.02%)

After-hours: Jun 23, 2026, 6:34 PM EDT

Boston Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-	2,892	1,846	1,592	698	1,041
Depreciation & Amortization	1,394	1,368	1,269	1,196	1,136	1,093
Stock-Based Compensation	308	299	266	233	220	194
Other Adjustments	-604	221	515	254	478	-106
Change in Receivables	-279	-269	-351	-238	-220	-279
Changes in Inventories	-256	-188	-228	-660	-321	-346
Changes in Accounts Payable	169	296	243	118	-255	408
Changes in Other Operating Activities	-117	-85	-126	10	-209	-134
Operating Cash Flow	4,341	4,534	3,435	2,503	1,526	1,870
Operating Cash Flow Growth	13.88%	31.99%	37.23%	64.02%	-18.40%	24.01%
Capital Expenditures	-866	-876	-790	-711	-588	-554
Sale of Property, Plant & Equipment	-	-	-	-	12	14
Purchases of Investments	-116	-254	-280	-89	-24	-
Proceeds from Sale of Investments	-	-	-	-	-	279
Payments for Business Acquisitions	-1,877	-1,593	-4,640	-1,811	-1,542	-2,258
Proceeds from Business Divestments	-	-	-	-	5	826
Other Investing Activities	90.5	84	23	37	126	97
Investing Cash Flow	-2,731	-2,640	-5,687	-2,574	-2,011	-1,597
Short-Term Debt Repaid	-771	-	-25	-4	-250	-
Net Short-Term Debt Issued (Repaid)	-771	-	-25	-4	-250	-
Long-Term Debt Issued	-	1,558	2,145	-	3,270	-
Long-Term Debt Repaid	-	-	-	-	-3,184	-
Net Long-Term Debt Issued (Repaid)	-	1,558	2,145	-	86	-
Issuance of Common Stock	228	282	230	182	136	110
Repurchase of Common Stock	-98	-131	-87	-56	-53	-50
Net Common Stock Issued (Repurchased)	130	151	143	126	83	60
Preferred Share Dividends Paid	-	-	-	-	-55	-55
Other Financing Activities	-42.5	-1,908	-328	-303	-411	-100
Financing Cash Flow	-888	-395	1,814	5	-548	-95
Effect of Exchange Rate Changes on Cash and Cash Equivalents	3	42	-11	-4	-9	-6
Net Cash Flow	723	1,541	-450	-70	-1,042	173
Free Cash Flow	3,475	3,658	2,645	1,792	938	1,316
Free Cash Flow Growth	-5.00%	38.30%	47.60%	91.05%	-28.72%	16.25%
FCF Margin	16.86%	18.22%	15.79%	12.58%	7.40%	11.07%
Free Cash Flow Per Share	2.32	2.45	1.78	1.22	0.65	0.91
Levered Free Cash Flow	3,118	4,971	4,341	1,519	241	1,452
Unlevered Free Cash Flow	3,932	3,602	2,474	1,832	771.77	1,626

SEC Filings: 10-K · 10-Q